|
Keeping up with the Chemos Series on Trastuzumab Deruxtecan ENHERTU®: Preparing to Give It (Pt. 1) |
|
Enduring |
|
$0.00 |
|
Keeping up with the Chemos Series: Lenvatinib/Pembrolizumab - Administration (Part 2) |
|
Enduring |
|
$0.00 |
|
NCI Grants for Training & Career Development |
|
Enduring |
|
$0.00 |
|
Sentinel Nodes |
|
Enduring |
|
$0.00 |
|
Session 3: Barriers to Care |
|
Enduring |
|
$0.00 |
|
Job Searches and Contract Negotiations: Career Considerations in the Time of COVID-19 |
|
Enduring |
|
$0.00 |
|
Scientific Plenary III: Novel Therapeutics: The Expanding Toolbox |
|
Enduring |
|
$0.00 |
|
2021 Update on Coding for Gynecologic Cancer |
|
Enduring |
|
$0.00 |
|
SGO Wellness Curriculum Sneak Peek Part 2: Moving from Surviving to Thriving |
|
Enduring |
|
$0.00 |
|
Targeted Treatment for Ovarian Cancer (Cocktail Part 1): Full Seminar |
|
Enduring |
|
$0.00 |
|
SGO Journal Club On-Demand: Advanced Endometrial Cancer—the Next Generation of Treatment |
|
Enduring |
|
$0.00 |
|
Gynecologic Oncology Gurus: Virtual Mentoring Session with Past SGO Presidents On-Demand |
|
Enduring |
|
$0.00 |
|
SGO 2021 Robotics Academy: Clinical Application of Robotic Surgery in Gynecologic Oncology: Colorectal Procedures |
|
Enduring |
|
$0.00 |
|
Keeping up with the Chemos Series on Trastuzumab Deruxtecan ENHERTU®: Administration (Pt. 2) |
|
Enduring |
|
$0.00 |
|
Keeping up with the Chemos Series: Lenvatinib/Pembrolizumab - Follow up Monitoring Between Cycles (Part 3) |
|
Enduring |
|
$0.00 |
Facebook
Twitter
LinkedIn
Forward